Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework
MJ Akiyama, N Kronfli, J Cabezas… - The lancet …, 2021 - thelancet.com
Hepatitis C virus (HCV) is a global public health problem in correctional settings. The
International Network on Health and Hepatitis in Substance Users–Prisons Network is a …
International Network on Health and Hepatitis in Substance Users–Prisons Network is a …
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
AD Marshall, AR Willing, A Kairouz… - The Lancet …, 2024 - thelancet.com
Direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection have delivered high
response rates (> 95%) and simplified the management of HCV treatment, permitting non …
response rates (> 95%) and simplified the management of HCV treatment, permitting non …
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study
B Hajarizadeh, J Grebely, M Byrne, P Marks… - The Lancet …, 2021 - thelancet.com
Background Limited empirical evidence exists for the effectiveness of hepatitis C virus (HCV)
treatment-as-prevention. The Surveillance and Treatment of Prisoners with hepatitis C …
treatment-as-prevention. The Surveillance and Treatment of Prisoners with hepatitis C …
HCV testing and treatment initiation in an Italian prison setting: a step-by-step model to micro-eliminate hepatitis C
V Fiore, G De Matteis, R Ranieri, L Saderi… - International Journal of …, 2021 - Elsevier
Background HCV infection among vulnerable populations is currently a major issue for HCV
elimination program. Incarcerated people and people who inject drugs (PWIDs) are key …
elimination program. Incarcerated people and people who inject drugs (PWIDs) are key …
Hepatitis C virus reinfection following direct-acting antiviral treatment in the prison setting: the SToP-C study
Background Injection drug use (IDU) following treatment for hepatitis C virus (HCV) infection
may lead to reinfection, particularly if access to harm reduction services is suboptimal. This …
may lead to reinfection, particularly if access to harm reduction services is suboptimal. This …
HCV microelimination for high-risk special populations
CF Huang, GJ Chen, CC Hung… - The Journal of Infectious …, 2023 - academic.oup.com
Abstract The World Health Organization has set tremendous goals to eliminate viral hepatitis
by 2030. However, most countries are currently off the track for achieving these goals …
by 2030. However, most countries are currently off the track for achieving these goals …
Elimination of hepatitis C virus infection among people who use drugs: ensuring equitable access to prevention, treatment, and care for all
There have been major strides towards the World Health Organization goal to eliminate
hepatitis C virus (HCV) infection as a global public health threat. The availability of simple …
hepatitis C virus (HCV) infection as a global public health threat. The availability of simple …
“That was quick, simple, and easy”: patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison
Introduction Current diagnostic pathways require multiple healthcare provider visits and lead
to a drop-off in the hepatitis C virus (HCV) testing and treatment care cascade. In prison …
to a drop-off in the hepatitis C virus (HCV) testing and treatment care cascade. In prison …
Reducing barriers to the hepatitis C care cascade in prison via point‐of‐care RNA testing: a qualitative exploration of men in prison using an integrated framework
Abstract Background and Aims Hepatitis C virus (HCV) is highly prevalent within the prison
setting. Although HCV testing and treatment are available within prisons, system barriers …
setting. Although HCV testing and treatment are available within prisons, system barriers …
[HTML][HTML] Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons …
Background Australia's prisons have a high chronic hepatitis C (HCV) prevalence (8%).
Antiviral therapies and prison-based hepatitis services are available, but only a minority of …
Antiviral therapies and prison-based hepatitis services are available, but only a minority of …